Global Hypersomnia Treatment Market Size

Statistics for the 2023 & 2024 Global Hypersomnia Treatment market size, created by Mordor Intelligence™ Industry Reports. Global Hypersomnia Treatment size report includes a market forecast to 2029 and historical overview. Get a sample of this industry size analysis as a free report PDF download.

Market Size of Global Hypersomnia Treatment Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Hypersomnia Treatment Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 8.70 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Hypersomnia Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Hypersomnia Treatment Market Analysis

The Hypersomnia Treatment market is projected to register a CAGR of 8.7% during the forecast period (2022 - 2027).

Since the COVID-19 pandemic, the proportion of sleeping disorder complaints has risen drastically. The sleep disorders were characterized as intrinsic (arising from the body), extrinsic (due to environmental conditions), or disturbances to circadian rhythm. The social isolation and interruption of daily routines during the COVID-19 lockdown have caused a rise in psychological stress among people, which in turn has increased sleep disorders all over the world. An article presented in the Journal of Clinical Sleep Medicine in February 2021 deduced that around 40% of the general and healthcare populations had reported various sleep problems during the COVID-19 pandemic. Excessive daytime sleepiness because of varied bedtime schedules is also one of the major causes of hypersomnia. Thus, there is an increasing demand for the hypersomnia treatment market to prevent further sleep disorders that arise due to COVID-19.

The Sleep Foundation (a Onecare Media Company), in its March 2022 article on 'Sleep Guidelines During the COVID-19 Pandemic', described the various factors associated with the sleep disorders during COVID-19 include infection and COVID-19, disruption of daily life, caregiving, excess screen time, anxiety and worry, depression and isolation, stress and stress-related fatigue, and altered dreams. According to an article published in December 2021 in the Egyptian Journal of Neurology, Psychiatry, and Neurosurgery, post-COVID-19 sleep disturbances were commonly reported in the recovery period. Also, these sleep deficits had an impact on the physical and mental aspects of quality of life.

The increased diagnosis of hypersomnia cases is a major driver which is anticipated to boost the growth of the market. Several organizations, such as the National Center on Sleep Disorders Research, have advocated the need to address the growing concern. According to the Cigna Health and Life Insurance Company's (CHLIC) April 2020 article, it was observed that the sale of sleep disorder prescriptions increased by 14.8% from February 16 to March 15 of the year compared to the same period in 2019. The surge in the development of pipeline drugs and the increase in lifestyle diseases, especially anxiety and depression, are expected to propel the growth of the market in the forecast period. However, the side effects of sleep disorder drugs are expected to limit the growth of the market.

Hypersomnia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)